顶层设计定调！医疗器械ETF（562600）获得资金持续青睐

Core Viewpoint - The A-share market experienced fluctuations last week, with the Shanghai Composite Index showing a slight increase of 0.11%. There was a rise in risk-averse sentiment, leading to gains in sectors such as pharmaceuticals, film, and medical devices. The medical device ETF (562600) saw a net inflow of 20 million over five days, accounting for 29.19% of its trading volume. The "14th Five-Year Plan" emphasizes support for innovative drugs and medical devices, aiming to drive economic growth through breakthroughs in key technologies in biomanufacturing and brain-computer interfaces. This strategic arrangement aligns the pharmaceutical industry's upgrade with national economic optimization, promoting higher quality development in the sector. Looking ahead, overseas markets show advantages in price stability and healthcare payment, with leading medical device companies experiencing faster growth abroad compared to the domestic market. The focus in the domestic market is shifting towards high-barrier innovation sectors, with policies supporting AI and brain-computer interface products, which will catalyze the commercialization of new products [1]. Group 1 - The A-share market showed a slight increase of 0.11% last week, with fluctuations observed [1] - Medical device ETF (562600) received a net inflow of 20 million, representing 29.19% of its trading volume [1] - The "14th Five-Year Plan" emphasizes support for innovative drugs and medical devices, aiming for breakthroughs in key technologies [1] Group 2 - Overseas markets exhibit advantages in price stability and healthcare payment, with leading companies growing faster abroad [1] - The domestic market is shifting focus to high-barrier innovation sectors, supported by policies for AI and brain-computer interface products [1]